ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Covalon Technologies Ltd (QX)

Covalon Technologies Ltd (QX) (CVALF)

1,55
-0,01
(-0,64%)
Geschlossen 29 Juni 10:00PM

Covalon Technologies Ltd (QX) (CVALF) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
1,55
( -0,64% )
Gebot
1,54
Fragen
1,81
Volumen
9.050
1,55 Tagesbereich 1,5725
1,1601 52-Wochen-Bereich 2,14
Marktkapitalisierung
Handelsende
1,56
Handelsbeginn
1,56
Letzte Trade
1500
@
1.55
Letzter Handelszeitpunkt
Finanzvolumen
US$ 14.179
VWAP
1,5667
Durchschnittliches Volumen (3 Mio.)
US$ 9.930
Ausgegebene Aktien
27.618.077
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
43,34
Gewinn pro Aktie (EPS)
0,05
Erlöse (LTM)
32,68M
Nettogewinn (LTM)
1,64M

Über Covalon Technologies Ltd (QX)

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company’s platform ... Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company’s platform technologies comprises collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre- and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone. It also offers a medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, perioperative dressings, silicone dressings, vascular access line guards, and wound dressings; and surgical, peri-operative, and infection management products. It sells its products directly and through independent distributors under the ColActive, ColActive PLUS, CovaWound, CovaView, CovaClear IV, IV Clear, SurgiClear, MediClear, and VALGuard brands. The company serves health care providers, such as hospitals, wound care centers, burn centers, extended/alternate care facilities, acute care facilities, home health care agencies, and physicians’ offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Website
Hauptsitz
Mississauga, Canada
Gegründet
-
Covalon Technologies Ltd (QX) is listed in the Healthcare sector of the OTC Markets with ticker CVALF. The last closing price for Covalon Technologies (QX) was US$1,56. Over the last year, Covalon Technologies (QX) shares have traded in a share price range of US$ 1,1601 to US$ 2,14.

Covalon Technologies (QX) currently has 27.618.077 shares in issue. The market capitalisation of Covalon Technologies (QX) is US$42,81 million. Covalon Technologies (QX) has a price to earnings ratio (PE ratio) of 43.34.

CVALF Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.02-1.273885350321.571.5991.54136041.5797495CS
4-0.044-2.760351317441.5941.611.45112801.55416561CS
120.2317.42424242421.321.631.373601.48777921CS
260.3630.25210084031.191.631.160194871.37391109CS
52-0.2499-13.88410467251.79992.141.1601102251.49899379CS
1560.2418.3206106871.313.080.7285123261.9334587CS
2600.3800132.47976478431.169993.080.7285104291.91223989CS

CVALF - Frequently Asked Questions (FAQ)

What is the current Covalon Technologies Ltd (QX) share price?
The current share price of Covalon Technologies Ltd (QX) is US$ 1,55
How many Covalon Technologies Ltd (QX) shares are in issue?
Covalon Technologies Ltd (QX) has 27.618.077 shares in issue
What is the market cap of Covalon Technologies Ltd (QX)?
The market capitalisation of Covalon Technologies Ltd (QX) is USD 42,81M
What is the 1 year trading range for Covalon Technologies Ltd (QX) share price?
Covalon Technologies Ltd (QX) has traded in the range of US$ 1,1601 to US$ 2,14 during the past year
What is the PE ratio of Covalon Technologies Ltd (QX)?
The price to earnings ratio of Covalon Technologies Ltd (QX) is 43,34
What is the cash to sales ratio of Covalon Technologies Ltd (QX)?
The cash to sales ratio of Covalon Technologies Ltd (QX) is 1,83
What is the registered address of Covalon Technologies Ltd (QX)?
The registered address for Covalon Technologies Ltd (QX) is 1660 Tech Avenue, Mississauga, Ontario, L4W 5S7
What is the Covalon Technologies Ltd (QX) website address?
The website address for Covalon Technologies Ltd (QX) is covalon.com
Which industry sector does Covalon Technologies Ltd (QX) operate in?
Covalon Technologies Ltd (QX) operates in the Biotechnology & Life Sciences sector

CVALF Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen